CompletedNot Applicable

ICBT for Psychological Symptoms Related to the COVID-19 Pandemic Remaining After Societal Opening

Sweden24 participantsStarted 2023-02-01

Plain-language summary

This study aim to investigate the effects of internet-based cognitive behavioral therapy (ICBT) addressing psychological symptoms related to the COVID-19 pandemic and its consequences that remain after societal opening. The target group is adults (18 years or older) who still experience psychological symptoms related to the pandemic and the ICBT consists of eight modules during eight week with weekly support by a therapist. ICBT will be compared to a wait-list control condition. Participants will be recruited in Sweden with nationwide recruitment.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Experience mental health problems related to the COVID-19 pandemic and/or its consecuences, which are still experienced as a problem (when the pandemic is not considered as dangerous to the society) * 18 years or older * Adequate ability to speak, read and write in Swedish * Having access to the internet and a smartphone, computer or other device Exclusion Criteria: * Severe psychiatric or somatic issues that makes participation harder or impossible (which can include the diagnosis postcovid) * Ongoing addiction * Acute suicidality * Other ongoing psychological treatment * Recent (within the past 3 months) changes in the dose of psychotropic medication or planned change during the treatment weeks

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Becks Depression Inventory-II

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.

Generalized Anxiety Disorder-7

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.

Trial details

NCT IDNCT05656430

SponsorLinkoeping University

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-09-30

View on ClinicalTrials.gov More Depression Symptoms trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Becks Depression Inventory-II

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.

Generalized Anxiety Disorder-7

Timeframe: Change between baseline, end of treatment after eight weeks and follow-up at 12 months after treatment termination.